Rational choices for allocating antiretrovirals in Africa: Treatment equity, epidemiological efficiency, and feasibility [1]

PLoS Medicine

Volumn 3, Issue 3, 2006, Pages 410-411

  Wilson, David P ^a   Blower, Sally M ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CLINICAL PRACTICE; FEASIBILITY STUDY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HERPES; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MATHEMATICAL MODEL; PREVALENCE; PROSTITUTION; ADULT; DECISION MAKING; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; NOTE; PREGNANCY; PREGNANCY COMPLICATION; VIRUS LOAD;

ADULT; AFRICA; ANTI-RETROVIRAL AGENTS; DECISION MAKING; FEMALE; HEALTH CARE RATIONING; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 33645332623     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030160     Document Type: Letter

References (4)

1. Rosen S, Sanne I, Collier A, Simon JL (2005) Rationing antiretroviral therapy for HIV/AIDS in Africa: Choices and consequences. PLoS Med 2: e303. DOI: 10.1371/journal.pmed.0020303
2. Blower S, Wald A, Gershengorn H, Wang F, Corey L (2004) Targeting virological core groups: A new paradigm for controlling herpes simplex virus type 2 epidemics. J Infect Dis 190: 1610-1617.
3. Wilson DP, Blower SM (2005) Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med 2: e50. DOI: 10.1371/journal.pmed.0020050
4. Blower S, Bodine E, Kahn J, McFarland W (2005) The antiretroviral rollout and drug-resistant HIV in Africa: Insights from empirical data and theoretical models. AIDS 19: 1-14.